Blurry vision is an unwanted side effect when trying to treat myopia or nearsightedness in school-aged children. As such, atropine eye drops are not prescribed at full strength of 1% like they are in amblyopia treatment or in pain management. Instead, a much-reduced concentration of 0.01%, 0.025%, or 0.05% is used and is why we refer to it as low-dose-atropine therapy.
The concentration of atropine used is based on the child's level of myopia, risk factors, and how well they tolerate the medication. In most cases, we start with the lowest concentration and adjust our treatment strategy over time based on results.